-
BIXT Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
-
Shorts
Bioxytran (BIXT)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Jan 25 | Anders Utter | preferred | Grant | Acquire A | No | No | 0.315 | 97,535 | 30.72 k | 333,992 |
6 Jan 25 | Conaway Dale H | Preferred | Grant | Acquire A | No | No | 0.315 | 97,535 | 30.72 k | 330,172 |
6 Jan 25 | Radka Milanova | Preferred | Grant | Acquire A | No | No | 0.315 | 97,535 | 30.72 k | 154,683 |
6 Jan 25 | Hoberman Alan M | Preferred | Grant | Acquire A | No | No | 0.315 | 97,535 | 30.72 k | 367,202 |
25 Oct 24 | Hoberman Alan M | preferred | Grant | Acquire A | No | No | 0.46 | 20,619 | 9.48 k | 269,667 |